Literature DB >> 18475670

Nitric oxide as a mediator of inflammation?-You had better believe it.

M J Miller1, M B Grisham.   

Abstract

Nitric oxide has enigmatic qualities in inflammation. In order to appreciate the precise contributions of nitric oxide to a pathophysiological process, one must account for enzyme source, coproduction of oxidants and antioxidant defences, time, rate of nitric oxide production, cellular source, peroxynitrite formation and effects on DNA (mutagenesis/apoptosis). We contend that there is ample evidence to consider nitric oxide as a molecular aggressor in inflammation, particularly chronic inflammation. Therapeutic benefit can be achieved by inhibition of inducible nitric oxide synthase and not the donation of additional nitric oxide. Furthermore, there is growing appreciation that nitric oxide and products derived thereof, are critical components linking the increased incidence of cancer in states of chronic inflammation.

Entities:  

Year:  1995        PMID: 18475670      PMCID: PMC2365674          DOI: 10.1155/S0962935195000639

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  83 in total

1.  L-nitroarginine, an inhibitor of NO synthase, dramatically worsens limbic epilepsy in rats.

Authors:  G Rondouin; J Bockaert; M Lerner-Natoli
Journal:  Neuroreport       Date:  1993-09-03       Impact factor: 1.837

2.  The nitric oxide synthase inhibitor, L-NG-monomethylarginine, reduces carrageenan-induced pleurisy in the rat.

Authors:  W R Tracey; M Nakane; J Kuk; G Budzik; V Klinghofer; R Harris; G Carter
Journal:  J Pharmacol Exp Ther       Date:  1995-06       Impact factor: 4.030

3.  Agonist-induced peroxynitrite production from endothelial cells.

Authors:  N W Kooy; J A Royall
Journal:  Arch Biochem Biophys       Date:  1994-05-01       Impact factor: 4.013

4.  Inhibition of nitric oxide formation does not protect murine cortical cell cultures from N-methyl-D-aspartate neurotoxicity.

Authors:  S J Hewett; J A Corbett; M L McDaniel; D W Choi
Journal:  Brain Res       Date:  1993-10-22       Impact factor: 3.252

5.  A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds.

Authors:  S A Lipton; Y B Choi; Z H Pan; S Z Lei; H S Chen; N J Sucher; J Loscalzo; D J Singel; J S Stamler
Journal:  Nature       Date:  1993-08-12       Impact factor: 49.962

Review 6.  Nitric oxide synthase inhibition and cerebrovascular regulation.

Authors:  C Iadecola; D A Pelligrino; M A Moskowitz; N A Lassen
Journal:  J Cereb Blood Flow Metab       Date:  1994-03       Impact factor: 6.200

7.  Nitric oxide-induced microvascular permeability alterations: a regulatory role for cGMP.

Authors:  P Kubes
Journal:  Am J Physiol       Date:  1993-12

8.  Endotoxin-stimulated nitric oxide production increases injury and reduces rat liver chemiluminescence during reperfusion.

Authors:  T T Ma; H Ischiropoulos; C A Brass
Journal:  Gastroenterology       Date:  1995-02       Impact factor: 22.682

9.  Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice.

Authors:  A H Cross; T P Misko; R F Lin; W F Hickey; J L Trotter; R G Tilton
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

10.  Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage.

Authors:  C Iadecola; F Zhang; X Xu
Journal:  Am J Physiol       Date:  1995-01
View more
  10 in total

1.  Effects of nonsteroidal anti-inflammatory drugs on Helicobacter pylori-infected gastric mucosae of mice: apoptosis, cell proliferation, and inflammatory activity.

Authors:  T I Kim; Y C Lee; K H Lee; J H Han; C Y Chon; Y M Moon; J K Kang; I S Park
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Na+ - and Cl- -coupled active transport of nitric oxide synthase inhibitors via amino acid transport system B(0,+).

Authors:  T Hatanaka; T Nakanishi; W Huang; F H Leibach; P D Prasad; V Ganapathy; M E Ganapathy
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

3.  Pharmacodynamic interactions between recombinant mouse interleukin-10 and prednisolone using a mouse endotoxemia model.

Authors:  Abhijit Chakraborty; Sally Yeung; Nancy A Pyszczynski; William J Jusko
Journal:  J Pharm Sci       Date:  2005-03       Impact factor: 3.534

4.  Carvacrol attenuates mechanical hypernociception and inflammatory response.

Authors:  Adriana G Guimarães; Maria A Xavier; Marília T de Santana; Enilton A Camargo; Cliomar A Santos; Fabíola A Brito; Emiliano O Barreto; Sócrates C H Cavalcanti; Angelo R Antoniolli; Rita C M Oliveira; Lucindo J Quintans-Júnior
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-12-03       Impact factor: 3.000

5.  The clinical and immunologic features of pulmonary fibrosis in sarcoidosis.

Authors:  Karen C Patterson; Kyle Hogarth; Aliya N Husain; Anne I Sperling; Timothy B Niewold
Journal:  Transl Res       Date:  2012-04-10       Impact factor: 7.012

6.  Failure of L-NAME to cause inhibition of nitric oxide synthesis: role of inducible nitric oxide synthase.

Authors:  M J Miller; J H Thompson; X Liu; S Eloby-Childress; H Sadowska-Krowicka; X J Zhang; D A Clark
Journal:  Inflamm Res       Date:  1996-06       Impact factor: 4.575

7.  Inhibition of NO-synthase and degranulation of rat omental mast cells in vitro.

Authors:  A M Northover; B J Northover
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

8.  The puzzling inflammatory bowel disease: growing interest for mediators of inflammation.

Authors:  F J Zijlstra
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

9.  Nitric oxide function in atherosclerosis.

Authors:  K E Matthys; H Bult
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

10.  Nitric oxide decreases intestinal haemorrhagic lesions in rat anaphylaxis independently of mast cell activation.

Authors:  J C Tavares; A Moreno; M S Crespo
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.